Cytotoxicity evaluation of curcumin-loaded affibody-decorated liposomes against breast cancerous cell lines.


Journal

Journal of liposome research
ISSN: 1532-2394
Titre abrégé: J Liposome Res
Pays: England
ID NLM: 9001952

Informations de publication

Date de publication:
Jun 2021
Historique:
pubmed: 16 4 2020
medline: 29 10 2021
entrez: 16 4 2020
Statut: ppublish

Résumé

Curcumin is known as an effective anticancer herbal medicine but unfortunately, its bioavailability is poor which necessitate efforts for developing more efficient and specific delivery systems. Human epidermal growth factor receptor 2 (HER 2) due to its overexpression in various types of cancers, is demonstrated to be a good candidate as a target for anticancer therapy. In this study, cytotoxicity of curcumin encapsulated in ZHER2:342 Affibody-decorated liposome was investigated against SKBR3 and MCF-7 cancerous cell lines. Curcumin-containing liposomes were prepared from soybeans lecetin and cholesterol by thin-film hydration method. Affibody ZHER2:342 molecules

Identifiants

pubmed: 32292087
doi: 10.1080/08982104.2020.1755981
doi:

Substances chimiques

Antineoplastic Agents 0
Liposomes 0
Curcumin IT942ZTH98

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

189-194

Auteurs

Mahshid Moballegh-Nasery (M)

Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran.
Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.

Ali Mandegary (A)

Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
Department of Toxicology & Pharmacology, School of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran.

Touba Eslaminejad (T)

Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.

Majid Zeinali (M)

Biotechnology Research Center, Research Institute of Petroleum Industry (RIPI), Tehran, Iran.

Abbas Pardakhti (A)

Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.

Behzad Behnam (B)

Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
Department of Pharmaceutical Biotechnology, School of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran.

Mohadeseh Mohammadi (M)

Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH